Anixa Biosciences Inc
Anixa Biosciences Inc (ANIX) Implied Volatility Current
ANIX implied volatility is 0%. IV Rank is 1%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking ANIX implied volatility helps you identify when options premiums on Anixa Biosciences Inc are historically cheap or expensive, and where the best trades are hiding. Anixa Biosciences Inc implied volatility reflects the market's expectation of future price movement: when ANIX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Anixa Biosciences Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ANIX, tracking metrics like ANIX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ANIX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer.
The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ANIX implied volatility sits today versus where it has been. Our scanner ranks Anixa Biosciences Inc implied volatility against its historical range, surfaces extremes in ANIX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Anixa Biosciences Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of October 16, 2026
Trade options with IV on your side
Track ANIX IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→